The analysis included ADAM10 and ADAM17 concentrations in the tumor tissue and matched surgical margin, as well as selected clinical and laboratory parameters, such as TNM stage according to the 8th edition [20], the presence of selected comorbidities and SIR parameters: NLR and PLR. The gene discussed is ADAM10; the disease is neoplasm.